Cash

Trending Midterms Elections Politics Sports Culture Crypto Commodities Climate Economics Mentions Finance Tech & Science

Predict Live205 AccountSocial

MARKETS INVEST LIVE205

Product

Kalshi Pro Invest Markets Incentive program Institutions API & developers

Company

About Kalshi Research Blog Careers Policy Center Brand Kit

Help

Help Center FAQ Fee schedule Trading hours Regulatory Trust Center

© 2026 Kalshi Inc. · All rights reserved

Privacy Data Terms of Service Trading Prohibitions FAQ for Finance Professionals

Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.

Johnson & Johnson Earnings Call (time TBD)

JNJ

ReportsJan 26, 2027 · time not confirmed

Fiscal periodNot stated

Market capNot available

Consensus EPSNot covered

Year-ago EPSNot available

Expected changeNot available

Quarterly markets

What will Johnson & Johnson say during their next earnings call?

Rybrevant
89%
Firefly Bio
87%
Procedure
87%
China
86%
Tecvayli
86%
Caplyta
86%
Ottava
82%
Tariff
79%
Litigation
70%
Darzalex Faspro
68%
AI / Artificial Intelligence
34%
Halda Therapeutics
24%

3 more words trade on this call

Johnson & Johnson Earnings Call (time TBD) (JNJ) earnings | Kalshi